药物的生物可用性-目前的知识状态
Marlena Stielow1, Adrianna Witczyńska2, Natalia Kubryń2
1Bonkitel, 1A/14 Staszica Street, 85-014 Bydgoszcz, Poland.
Molecules (Basel, Switzerland)
|December 23, 2023
概括
药物的生物可用性是有效药理学和安全患者治疗的关键. 了解吸收,分布,新陈代谢和排泄对于实现所需的治疗效果和优化药物剂量至关重要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物开发 药物开发
- 临床药房 临床药房
背景情况:
- 药物的生物可用性对于治疗效果和患者安全至关重要.
- 了解药物吸收,分布,新陈代谢和排泄 (ADME) 是非常重要的.
- 患者因子,剂量和施用途径的变化需要生物可用性控制.
研究的目的:
- 突出药理学中药物生物可用性研究的重要性.
- 讨论生物可用性的基本概念和影响因素.
- 探索评估生物利用性和未来研究趋势的方法.
主要方法:
- 对生物可用性概念和影响因素的文献综述.
- 讨论生物可用性评估的实验室和临床方法.
- 分析生物可用性较差的药物所带来的挑战.
主要成果:
- 生物可用性直接影响药物在目标部位达到治疗度的能力.
- 由于患者间的变化,有效的生物利用性管理是优先考虑的.
- 新技术对于推动生物可用性研究至关重要.
结论:
- 药物的生物可用性是现代药理学和有效药物治疗的基石.
- 需要进一步的研究,以应对描述不佳的生物可用药物的挑战.
- 了解和控制生物可用性对于可靠的患者治疗和药物开发至关重要.
相关概念视频
Bioavailability: Overview
2.8K
Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
2.8K
Factors Influencing Bioavailability: First-Pass Elimination
6.4K
When a drug is taken orally, it undergoes a journey starting from the gastrointestinal (GI) tract, passing through the portal vein, reaching the liver, and finally entering the systemic circulation. This process involves the absorption of the drug across the GI tract. The liver is the primary site for metabolizing the drug, with some metabolism also occurring in the gut wall. This journey significantly reduces the quantity of the drug that reaches the systemic circulation, a phenomenon known as...
6.4K
Drug Concentrations: Measurements
375
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
375
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Distribution: Plasma Protein Binding
5.6K
Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
5.6K
Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K


